Aptar Digital Health Partners with Enable Injections for enFuse Companion Digital Solution

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable’s preferred digital health partner for the enFuse system. This digital solution will be designed to guide patients and caregivers throughout the injection process and help support engagement before, during, and after administration.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408418501/en/

Aptar Digital Health Enable Injections Inc. enFuse Digital Companion Solution

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse system designed to enhance the patient experience and support adherence-related programs. Key features of the solution may include treatment data recording, onboarding and training modules, injection guidance, patient-reported outcomes and symptom tracking - helping to empower patients and caregivers with greater confidence and control over the treatment process.

Built on a flexible and scalable architecture, the companion digital solution will be deployed alongside the enFuse system, enabling pharmaceutical partners to extend the value of their therapies beyond delivery. Designed to evolve across the drug development lifecycle, the digital solution may support use cases from clinical trials through commercialization, aligned with development and launch strategies.

Adherence data and patient reported outcomes will be captured remotely, securely stored and made available through analytics dashboards that generate actionable insights intended to support clinical development, launch readiness and real-world use. The modular, program-specific design will allow pharmaceutical partners to integrate digital components into their clinical or commercial programs based on their needs. By combining device-generated data with patient reported insights, the digital solution will help drive more informed decisions grounded in real-world usage.